Estée Lauder Companies (The)
EL · What the business does, what can go wrong, and how options sellers approach it
What it does
The Estée Lauder Companies makes and sells prestige beauty products. Its main categories are skin care, makeup, fragrance and hair care. Its brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown and Origins.
The company sells in many countries through department stores, travel retail, specialty beauty retailers, its own stores, e-commerce, salons and spas, and perfumeries.
How it makes money
EL earns revenue by selling products to retailers and directly to consumers. Prestige beauty tends to carry high gross margins, because brand image and perceived quality support premium prices. The company spends heavily on advertising, celebrity and creator partnerships, and in-store presentation to keep those brands desirable.
Skin care is the largest category. Sales are also spread across the Americas, Europe, the Middle East and Africa, and Asia-Pacific.
Why investors own it
Investors often view EL as a way to own a portfolio of well-known global beauty brands. Strengths people point to include brand loyalty, pricing power in premium categories, international reach, and the potential for profit margins to improve when sales are strong. The company has also historically paid a dividend, which appeals to some income-oriented holders.
What can go wrong
- Demand can weaken when consumers cut back on discretionary spending.
- Heavy exposure to travel retail and to Asian markets makes results sensitive to tourism flows and regional economic conditions.
- Competition from newer brands and mass-market rivals, plus weaker department store traffic, can pressure sales.
- Currency swings, tariffs and supply chain costs can hurt profits.
- Cost-cutting or reorganization efforts, when undertaken, may not deliver the expected savings.
What to watch
- Organic net sales growth by region and category
- Travel retail trends
- Mainland China demand
- Gross margin and operating margin
- Advertising and promotional spending
- Inventory levels at retailers
- Management guidance
- Dividend announcements
Options income angle
Options on EL are generally liquid, though spreads can be wider on less popular contracts. Implied volatility tends to rise ahead of earnings and guidance updates, and around news on Chinese demand, tariffs or travel retail.
One caution: a sharp drop after earnings can leave a put seller or covered call holder with a loss far larger than the premium collected, while a sharp rise can leave a covered call seller with capped upside.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended June 30, 2026, filed August 19, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
The company's fiscal year ended June 30, 2026 was a recovery year. Net sales grew and operating income swung back to a profit of $780 million after an operating loss of $785 million a year earlier, mostly because large asset write-downs did not repeat. The filing also says tariffs are expected to hurt fiscal 2027 profit and cash flow, and that some brand values have thin cushions.
How the business did
- Net sales rose 5% to $15,049 million from $14,326 million. Volume added 2%, foreign currency 2% and pricing 1%. Skin care and fragrance led, and every region grew.
- Operating income was $780 million, versus a loss the prior year that included $1,286 million of goodwill and other intangible asset impairments (write-downs of the value of acquired brands). Gross margin rose to 75.5% from 74.0%, which the company credits to its Profit Recovery and Growth Plan (PRGP), a cost-cutting program.
- Fragrance net sales grew 12% to $2,779 million, helped by Le Labo, TOM FORD and KILIAN PARIS. Mainland China net sales grew 12% to $3,058 million. The Americas grew 1%.
- Net earnings attributable to the company were $182 million, or $.50 per diluted share, after a net loss of $1,133 million. The effective tax rate was 64.8%. Restructuring and other charges were $813 million, and an $84 million securities class action settlement was recorded.
- Operating cash flow was $1,773 million versus $1,272 million. Cash and cash equivalents ended at $3,498 million. Dividends paid fell from the prior year.
Risks specific to this company
- Tariffs: Management anticipates tariffs will hurt fiscal 2027 profitability and cash flows, and the impact "could be material." It began receiving refunds of tariffs a court ruled unauthorized, but says the remaining refund amounts are not material.
- Brand write-down risk: The Dr.Jart+ trademark's estimated value exceeded its carrying value of $37 million by only 4%. The TOM FORD trademark, carried at $1,805 million, exceeded its carrying value by 19%. Weaker sales or higher discount rates could trigger new impairments.
- Debt and ratings: Total debt was 66% of total capitalization. S&P rates the long-term debt A- and Moody's rates it A3, both with negative outlooks. The filing says downgrades would raise borrowing costs.
- Litigation: Talc settlement agreements with certain plaintiff law firms cover potential future claims through December 31, 2029, subject to annual caps. The securities class action settlement still needs final court approval. The filing also names asbestos-related claims.
- Weak spots in sales: Management cites ongoing challenges in the United States and some Western European markets. In Asia travel retail, a change in the duty-free retailers serving the Beijing and Shanghai airports is creating transitory pressure. The company also says department store traffic has declined in the United States.
- Family control: The Lauder family holds about 82% of the voting power and four board seats. The company is a "controlled company" under New York Stock Exchange rules and uses exemptions from some governance requirements.
What management is watching
- Restructuring wrap-up: Approved initiatives are expected to be substantially completed by the end of fiscal 2027. Total charges are expected to reach $1,748 million before taxes, with a net reduction of approximately 10,000 positions. Annual gross benefits are targeted at approximately $1,200 million before taxes, part of it reinvested in consumer-facing activities.
- Strategy: The "Beauty Reimagined" plan centers on wider consumer coverage, new product innovation and more consumer-facing investment.
- Tariff response: Management is shifting sourcing and manufacturing toward the region where products are sold, where feasible, and using trade programs.
- Uncertainty: It is watching the Middle East conflict (locations affected were about 2% of net sales in fiscal 2025), inflation, currency swings and the possibility of further impairments or tax valuation allowances.
- Metrics: Management points investors to adjusted (non-GAAP) results that exclude one-time items. Examples are constant currency sales growth of 3%, adjusted operating income of $1,687 million and adjusted diluted earnings per share of $2.51.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed November 2, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Net sales for the three months ended September 30, 2026 were $3,715 million, up 7%, and net earnings rose to $233 million from $47 million. Fragrance, Mainland China and travel retail led the growth, and gross margin improved while restructuring charges fell. Management still expects tariffs to hurt fiscal 2027 profitability and cash flows.
How the business did
- Sales: Net sales rose from $3,481 million, up 6% in constant currency (a measure that removes exchange-rate swings). Volume rose 7%, pricing fell 1% because of product mix, and currency added 1%.
- Categories and regions: Fragrance net sales rose 19% to $861 million, led by Le Labo, TOM FORD, Jo Malone London and Estée Lauder. Skin care rose 5% to $1,651 million, driven by La Mer and The Ordinary. Makeup rose 2%, while hair care fell 1% as Aveda had lower shipments from brand-specific supply chain logistical challenges. Every region grew, led by Mainland China (up 15%) and Asia/Pacific (up 9%), helped by replenishment orders at the Beijing and Shanghai airports.
- Profit: Gross margin was 75.7% versus 73.4%. Operating income was $408 million versus $169 million, and operating margin was 11.0% versus 4.9%. Restructuring and other charges were $40 million versus $89 million. Diluted earnings per share were $.64 versus $.13, or $.72 versus $.32 excluding restructuring charges. The effective tax rate was 32.5% versus 56.9%. Higher advertising spending partly offset the gains.
- Cash and capital: Operating activities used $166 million of cash, versus $340 million used a year earlier. Cash and cash equivalents were $3,198 million, compared with $3,498 million at June 30, 2026. After quarter-end, on October 5, 2026, the company paid $160 million for the remaining 51% of the Forest Essentials brand's owner, plus a $37 million one-time inducement payment, using cash on hand.
What management is watching
- Tariffs: Tariffs hurt first-quarter results. Management anticipates an adverse effect on fiscal 2027 profitability and cash flows that could be material, depending on rates and countries. Its response includes sourcing and manufacturing in the region where products are sold, where feasible.
- Uneven markets: Management points to continued challenges in Western Europe and the United States, the change in duty-free retailers at the Beijing and Shanghai airports, and the conflict in the Middle East. Locations affected by that conflict made up approximately 2% of consolidated net sales in fiscal 2026 and 2025.
- Strategy and spending: The company is executing "Beauty Reimagined" and the Profit Recovery and Growth Plan, while raising consumer-facing investments such as advertising. It warns that falling sales and profit could lead to impairments of brand-related assets, and that a valuation allowance on deferred tax assets could be material.
- Measures cited: Management points investors to constant-currency growth and results adjusted to exclude restructuring and other charges.
Follow EL in Kortex
The Kortex app shows EL's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.